Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions

ABSTRACT: Background: HIV cure-directed clinical trials using analytical treatment interruptions (ATIs) require participants to adhere to frequent monitoring visits for viral load tests. Novel viral load monitoring strategies are needed to decrease participant burden during ATIs.Objective: To examine acceptability of a novel home-based blood collection device for viral load testing in the context of two ongoing ATI trials in Philadelphia, PA, United States.Methods: From January 2021 to February 2022, participants completed three in-depth interviews via teleconference during their participation in an ATI: (1) within two weeks of enrollment in the device study, (2) approximately four weeks after beginning to use the device, and (3) within two weeks of the end of the ATI when ART w

SUBMITTER: Dube K 

PROVIDER: S-EPMC9403870 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature